By Rick Berke, Executive Editor
May 14, 2026
In the landscape of American public health, certain crises command the headlines: the opioid epidemic, the surge in synthetic substances, and the ongoing battles over reproductive care. Yet, there is a catastrophe unfolding in plain sight—one that claims 178,000 lives annually, quietly devastating families and straining the nation’s medical infrastructure. That crisis is alcohol.
Today, STAT is proud to launch a landmark investigative series, “The Deadliest Drug.” This multi-part project represents the culmination of nearly a year of exhaustive research, aiming to expose why the U.S. has systematically failed to address excessive alcohol use, and why this preventable epidemic continues to spiral unimpeded.
The Core Investigation: A Systemic Failure
“The Deadliest Drug” is not merely a report on addiction; it is an examination of systemic failure. The series reveals that the staggering death toll—178,000 Americans per year—is not an inevitability, but the result of a generational collapse in public health policy, regulatory oversight, and medical intervention.
Our reporters, Isabella Cueto and Lev Facher, have spent months peeling back the layers of a complex ecosystem that profits from, yet refuses to address, the harms of alcohol. Their work draws upon more than 100 interviews with leading researchers, clinicians, industry insiders, and policymakers. By analyzing lobbying disclosures, clinical treatment protocols, and public health data, Cueto and Facher have synthesized a narrative that challenges the status quo.
The series argues that the current administration is squandering a unique opportunity to enact meaningful change, choosing instead to prioritize industry interests over the health of the citizenry.
Chronology of an Epidemic
To understand the current crisis, one must look at the historical trajectory of how alcohol has been treated—or ignored—within the halls of government and medicine.
- The Decades of Stagnation: For over 40 years, federal policy toward alcohol has been characterized by a lack of cohesive strategy. While opioids saw rapid, albeit imperfect, federal intervention, alcohol-related deaths have climbed steadily without a comparable national mobilization.
- The Modern Regulatory Landscape: Recent years have seen a shift in how alcohol is marketed and consumed. The proliferation of high-alcohol-content beverages and the easing of retail restrictions have created a "perfect storm" for consumption.
- The Current Turning Point: In early 2026, as mortality data began to show a sharp, undeniable spike in alcohol-related liver disease and accidental deaths, the demand for a federal response reached a fever pitch. Despite this, the current administration has faced intense criticism for its passivity, leading to the investigations featured in our series.
Supporting Data: The Cost of Complacency
The numbers behind “The Deadliest Drug” are as harrowing as they are clear. Our data editor, J. Emory Parker, has compiled original, visual-heavy analyses that ground the narrative in cold, hard reality.
- 178,000: The number of annual deaths directly linked to alcohol, a figure that continues to climb as medical systems fail to provide adequate, modern treatment.
- The Shift in Disease: As detailed in our reporting, we are witnessing a unique, alarming rise in specific types of alcohol-induced liver disease that were previously less common in the American demographic.
- Treatment Disparity: While the medical field has made strides in treating other forms of substance use disorder, alcohol treatment remains stuck in antiquated models. A centerpiece of our series explores the "seismic shift" currently occurring in 12-step programs and the transition toward more evidence-based, pharmacologically supported interventions.
Official Responses and Political Implications
The political fallout from this crisis is already manifesting in Washington. The intersection of health policy and the current administration’s agenda has created significant friction.
The FDA Under Fire
The series also examines the broader health environment, specifically the recent turbulence at the Food and Drug Administration. The resignation of Commissioner Marty Makary, widely criticized by industry experts as "the worst FDA commissioner in 25 years," serves as a backdrop to the regulatory paralysis we see regarding alcohol policy.
While the new acting commissioner is being viewed as a potential "drama-free" transition, the internal culture at the FDA remains fragile. A recent oral history published by STAT’s Lizzy Lawrence and Alex Hogan captured the voices of former staffers who described a "rebuilding" phase, noting that the agency’s capacity to regulate major health threats—including alcohol—has been significantly diminished by recent administrative turnover.
The Louisiana Primary and the Future of Health Legislation
Beyond federal agencies, our coverage extends to the legislative branch. The political fate of Senator Bill Cassidy, a key voice in health care, is currently hanging in the balance. Our D.C. reporting team traveled to Louisiana to interview constituents and stakeholders, finding that even if Cassidy survives his primary, his influence on national health policy has been severely compromised. This loss of legislative capital further complicates the path forward for any comprehensive alcohol-reform bill.
Implications: A Call to Action
The objective of “The Deadliest Drug” is to move the needle from indifference to action. By highlighting the failure of the medical and public health systems, we hope to ignite a broader conversation about how the U.S. handles substance use.
The series is not just about the failures of the past; it is about the possibilities of the future. We examine:
- The Evolution of Care: How the medical community is moving toward individualized treatment plans that go beyond traditional sobriety models.
- The Regulatory Gap: Why alcohol remains largely exempt from the same level of scrutiny applied to other public health threats, and how that can be corrected.
- Societal Awareness: A look at the startling rise in alcohol use during pregnancy and the long-term, intergenerational consequences of this trend.
As one prominent researcher noted after reviewing our early installments, this series is perhaps the most "comprehensive and accessible" exploration of the alcohol crisis ever produced.
Looking Ahead: The Role of Independent Journalism
At STAT, we believe that health journalism is a public service. In an era of increasing political noise, the need for rigorous, fact-based reporting on the health issues that affect every American family has never been greater.
In addition to our investigative series, our subscribers receive deep dives into the biotech and pharmaceutical sectors, exclusive access to our industry-leading newsletters, and priority invitations to events like our upcoming Breakthrough Summit West in San Francisco.
The crisis of alcohol use is not going away on its own. It requires the light of investigation, the rigor of data, and the commitment of a public that refuses to accept these deaths as the cost of doing business. We invite you to read the full series, explore the data, and join us in demanding a more serious, evidence-based approach to the nation’s deadliest drug.
For those interested in supporting this vital work, we are currently offering a three-month trial of STAT+ for just $30. Your subscription provides the resources necessary to keep our reporters in the field, investigating the stories that others are too afraid to touch.
If you have feedback or questions regarding our coverage, I invite you to reach out to me directly at [email protected].
